Article
House Oversight Committee subpoenas AbbVie over 'woefully inadequate' document production in price-
Rating:
0.0
Views:
157
Likes:
1
Library:
1
Congress is turning up the heat on AbbVie $ABBV over its pricing policies. The House Committee on Oversight and Reform is planning to subpoena the biopharma as part of a 2019 probe into the alleged price-gouging of Humira and Imbruvica, according to a memo released Monday. The move comes after
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value